Study of Cabozantinib and Nivolumab in Metastatic Castration Resistant Prostate Cancer
Clinical trial NCT05502315 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05502315
- Sponsor
- Rana McKay, MD
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-02
- Primary completion
- 2026-07-12
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.